Skip to main content

Specialty Pharmacy

  • Studies: Esbriet can improve life expectancies for idiopathic pulmonary fibrosis patients

    ALEXANDRIA, Va. — Pirfenidone (Esbriet) can improve life expectancy compared with best supportive care and lower the risk of lung function decline for patients with idiopathic pulmonary fibrosis, an irreversible and unpredictable disease of unknown etiology that makes breathing difficult and causes permanent scarring damage to the lungs, according to two studies published in the March issue of the Journal of Managed Care & Specialty Pharmacy.

  • Hy-Vee switches up Amber Pharmacy leadership
    WEST DES MOINE, Ia. — Hy-Vee on Monday announced a change of leadership at Amber Pharmacy. The company has named Aaron Wiese, previously Hy-Vee assistant VP and Amber Pharmacy president, to the position of Hy-Vee VP strategy/innovation, and as a result, Mike Agostino has returned to the position of president of Amber Pharmacy.
     
    Aaron Wiese

  • Cost issues aside, outlook solid for continued rise of specialty Rx

    Specialty and biotech medicines aimed at treating cancer, multiple sclerosis and rare diseases will dominate much of drug development in 2017 and beyond, one of the nation’s top specialty pharmacy providers concluded.

    (To view the full Category Review, click here.)

  • Key approvals see big sales in first months

    Among the 22 novel new drugs approved by the Food and Drug Administration in 2016, about half were considered specialty drugs, and Diplomat identified four key specialty approvals that innovate in certain categories. Two of these were in the hepatitis C space, which has driven specialty growth for several years.

    (To view the full Category Review, click here.)

  • Fred's February sales decline, but company pleased with progress

    MEMPHIS, Tenn. — Fred’s Pharmacy reported total sales for its fiscal month of February, which ended Feb. 25, decreased 3.5% on a year-over-year basis to $165.4 million. Total comparable store sales declined 4%, compared with an 0.8% increase during the same time period in 2016.

    Fred’s CEO Michael K. Bloom stressed the company is pleased with progress it is making under its strategic plan though.

  • CVS selects electronic health record system for specialty care

    WOONSOCKET, R.I. — CVS Health on Thursday selected Epic as the electronic health record system for CVS Specialty’s care management programs.

    According to CVS, the transition to Epic will help integrate and improve clinical processes for CVS Specialty, including Accordant, which provides care management program services for patients with rare, chronic diseases. This announcement expands the Company's use of the Epic EHR system beyond MinuteClinic which transitioned to the system in 2015.

  • Walgreens designates more than 50 specialty pharmacies as cancer-specialized centers

    DEERFIELD, Ill. — Walgreens on Wednesday designated more than 50 of its local specialty pharmacies as cancer-specialized locations. Each of the locations will be led by pharmacists and pharmacy technicians who have advanced cancer training and expertise and are committed to making sure patients get the medications and answers they need.

  • PhRMA names new leads on state advocacy, strategic alliances
    WASHINGTON — The Pharmaceutical Research and Manufacturers of America has announced leadership changes to some of its advocacy efforts as longtime SVP advocacy Jeff Bond is set to retire. The organization named SVP Scott LaGanga as head of PhRMA state advocacy, assuming Bond’s responsibilities. Shannon Graham has been named SVP and will lead PhRMA’s advocacy and strategic alliances program. 
     
X
This ad will auto-close in 10 seconds